About Korean vaccine
Korean vaccine is a company based in Ansan-si (South Korea) founded in 1956. It operates as a B2B and Contract Manufacturing. Korean vaccine offers products and services including Coboxflu4gaPF Injection, Coboxinplu4gaPF Injection, Syringe, Needle, and Catheter. Korean vaccine operates in a competitive market with competitors including Hospira, 410 Medical, Ivenix, Belmont Medical Technologies and IRadimed, among others.
- Headquarter Ansan-si, South Korea
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name (주)한국백신
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Korean vaccine
Korean vaccine offers a comprehensive portfolio of products and services, including Coboxflu4gaPF Injection, Coboxinplu4gaPF Injection, Syringe, Needle, and Catheter.
Influenza vaccine for seasonal flu prevention and protection.
Divided influenza vaccine for immunization purposes.
Device for vaccine administration and medical injections.
Component for safe delivery of vaccines and fluids.
Tool for medical procedures and fluid management.
System for intravenous delivery of medications.
Funding Insights of Korean vaccine
Investments & Acquisitions by Korean vaccine
Financial Statements - Korean vaccine
Korean Vaccine Comparisons
Competitors of Korean vaccine
Korean vaccine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hospira, 410 Medical, Ivenix, Belmont Medical Technologies and IRadimed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Injectable drugs, infusion technologies, and biosimilars are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Rapid infusion systems are provided for critically ill patients.
|
|
| domain | founded_year | HQ Location |
Infusion management systems are developed with wireless web-based architecture.
|
|
| domain | founded_year | HQ Location |
Fluid management and critical care medical devices are developed.
|
|
| domain | founded_year | HQ Location |
Developer of IV Infusion system and patient monitoring systems for the MRI setting
|
|
| domain | founded_year | HQ Location |
Medical devices for infusion therapy, monitoring, and radiology are manufactured.
|
Latest news on Korean Vaccine
Frequently Asked Questions about Korean vaccine
Korean vaccine was founded in 1956.
Korean vaccine is headquartered in Ansan-si, South Korea. It is registered at Ansan-si, Gyeonggi-do, South Korea.
Korea Vaccine is a South Korean company that produces influenza vaccines and other bio pharmaceuticals, offering contract manufacturing, storage, and analytical services. It operates facilities in Ansan and Seoul, serving global clients through WHO-standard GMP compliance and overseas expansions like in Indonesia. The company focuses on RD for medical products and ensures ethical, environmentally safe operations.
Korean vaccine's top competitors include 410 Medical, IRadimed and Belmont Medical Technologies.
Korean vaccine offers Coboxflu4gaPF Injection, Coboxinplu4gaPF Injection, Syringe, Needle, and 2 more products and services.